| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/17/2003 | US20030134424 For implanting/transfecting monodispersed silicon particles joined to DNA into target tissue, cell or the blood stream |
| 07/17/2003 | US20030134423 Lipid aggregates (liposomes) for transfection of nucleic acids |
| 07/17/2003 | US20030134420 Methods and compositions for gene delivery |
| 07/17/2003 | US20030134387 Vertebrate globin |
| 07/17/2003 | US20030134350 Zinc finger domain recognition code and uses thereof |
| 07/17/2003 | US20030134314 Assaying the ability of specific polypeptide activity, thereby identifying a compound capable of treating a hematologic disorder |
| 07/17/2003 | US20030133912 Receptor-targeted adenoviral vectors |
| 07/17/2003 | US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 07/17/2003 | US20030133910 Inhibiting cell proliferation by administering a large dosage of wild-type ras proteins |
| 07/17/2003 | US20030133909 An isolated polynucleotide encodes a polypeptide which comprising amino acids able to glycosylation, vaccines as an antitumor agent for treating mammal |
| 07/17/2003 | DE20302861U1 Bio-compatible electrode, for in vivo electroporation, comprises a hydrogel coating as a barrier between electrochemical reactions and the biological target |
| 07/17/2003 | CA2472647A1 Mammal prolactin variants |
| 07/17/2003 | CA2472282A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | CA2472118A1 Pak5-related compositions and methods |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2471432A1 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/17/2003 | CA2470411A1 System for monitoring bacterial tumor treatment |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | CA2469177A1 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes |
| 07/16/2003 | EP1327688A1 Adenoviruses with enhanced lytic potency |
| 07/16/2003 | EP1327683A2 Human papilloma virus inhibition by a hairpin ribozyme |
| 07/16/2003 | EP1327003A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326988A1 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 07/16/2003 | EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
| 07/16/2003 | EP1326973A2 Regulation of human gpcr-like protein |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326969A2 Improved system for regulation of transgene expression |
| 07/16/2003 | EP1326892A2 Compositions that inhibit proliferation of cancer cells |
| 07/16/2003 | EP1326879A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 07/16/2003 | EP1326839A2 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
| 07/16/2003 | EP1326646A2 Transferrin-polycation/dna complexes for the systemic treatment of tumour diseases using cytotoxic proteins |
| 07/16/2003 | EP1326645A1 Complexes for transferring nucleic acids into cells |
| 07/16/2003 | EP1326632A2 Agents for the treatment of viral infections |
| 07/16/2003 | EP1326630A2 Use of glp-1 and glp-2 peptides |
| 07/16/2003 | EP1326627A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 07/16/2003 | EP1019510B1 Vaccines derived from porcine circoviruses |
| 07/16/2003 | CN1430675A Use of baculovirus vectors in gene therapy |
| 07/16/2003 | CN1430626A Sheep lice Bobicola ovis allergen treatment |
| 07/16/2003 | CN1429911A Slow virus carrier system, method of producing carrier and its application |
| 07/16/2003 | CN1429561A Non-operation method of constructing human/goat mosaic |
| 07/16/2003 | CN1114690C Papilloma pseudovirus and process for preparing same |
| 07/15/2003 | US6593466 Guanidinium functionalized nucleotides and precursors thereof |
| 07/15/2003 | US6593463 Malarial merozite surface protein (MSP); modified nucleic acid sequence; AT content has been reduced by replacing codons with mammary gland preferred codons; useful in development of a vaccine against malaria |
| 07/15/2003 | US6593461 Isolated DNA of given nucleotide sequence which encodes an amino acid sequence; hybridization; use in diagnosing, preventing and treating gastrointestinal disorders |
| 07/15/2003 | US6593456 Polypeptide for use in the treatment rheumatoid arthritis |
| 07/15/2003 | US6593147 Detection of prefrential particles in humans; obtain fluid sample, incubate with antibody, detect formation of immunocomplex |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/15/2003 | US6593132 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 07/15/2003 | US6593119 Core 2 β-1,6-N-acetylglycosaminyltransferase gene |
| 07/15/2003 | US6593112 Polynucleotides encoding fibroblast growth factor 15 |
| 07/15/2003 | US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases |
| 07/15/2003 | US6592874 Togavirus capsid particle that does not contain genomic or RNA vector replicon nucleic acids |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592862 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/10/2003 | WO2003056022A2 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 07/10/2003 | WO2003056019A1 Method of transducing es cells |
| 07/10/2003 | WO2003056013A1 TGF-β-SPECIFIC COVALENTLY CLOSED ANTISENSE MOLECULE |
| 07/10/2003 | WO2003056012A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | WO2003055983A2 Targeted retrograde gene delivery to motor neurons |
| 07/10/2003 | WO2003055981A2 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions |
| 07/10/2003 | WO2003055980A2 Il-17 like molecules and uses thereof |
| 07/10/2003 | WO2003055915A2 Human netrin receptor and uses thereof |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | WO2003055529A1 Dna vaccine for periodontal disease |
| 07/10/2003 | WO2003055506A1 Preventives/remedies for cancer |
| 07/10/2003 | WO2003055505A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders |
| 07/10/2003 | WO2003055411A2 Implantable device and the use thereof |
| 07/10/2003 | WO2003055302A1 Knockout swine and methods for making the same |
| 07/10/2003 | WO2003023015A3 Method for expression of small antiviral rna molecules within a cell |
| 07/10/2003 | WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 07/10/2003 | WO2003002765A3 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 07/10/2003 | WO2002102412A3 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons |
| 07/10/2003 | WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap) |
| 07/10/2003 | WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs |
| 07/10/2003 | WO2002063008A3 Intracellular signaling molecules |
| 07/10/2003 | WO2002043570A3 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES |
| 07/10/2003 | WO2002040538A8 Regulation of human nmda receptor |
| 07/10/2003 | WO2002013845A3 Inflammation related g-protein coupled receptor |
| 07/10/2003 | WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 07/10/2003 | WO2001096559A3 Regulatable, catalytically active nucleic acids |
| 07/10/2003 | WO2001096523A3 Polynucleotides related to colon cancer |
| 07/10/2003 | WO2001089364A9 Hcv variants |
| 07/10/2003 | US20030131366 Non-human mammals comprising cells expressing vector-borne mouse PTTG carboxy-terminal-related DNA |
| 07/10/2003 | US20030130626 Apparatus with weeping tip and method of use |
| 07/10/2003 | US20030130495 G-protein coupled receptors, signal transduction pathways |
| 07/10/2003 | US20030130493 Endothelial Differentiation Gene (Edg), neuroregulators, phospholipid metabolism, nervous systems |
| 07/10/2003 | US20030130224 In muscle cells; supplying polynucleotide in situ by injection |
| 07/10/2003 | US20030130223 Gene therapy composition for treating arthritis |
| 07/10/2003 | US20030130222 Apoptosis; modulate gene expression; central nervous system disorders; anticancer agents; Aids therapy |
| 07/10/2003 | US20030130221 Induction of tolerance to a therapeutic polypeptide |
| 07/10/2003 | US20030130219 Classification of genes; medical diagnosis |
| 07/10/2003 | US20030130218 Methods of stimulating phagocytosis |
| 07/10/2003 | US20030130217 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 07/10/2003 | US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease |